Genetic characterization and diversity of circulating influenza A/H1N1pdm09 viruses isolated in Jeddah, Saudi Arabia between 2014 and 2015
- 157 Downloads
The emerged influenza A/H1N1pdm09 viruses have replaced the previously circulating seasonal H1N1 viruses. The close antigenic properties of these viruses to the 1918 H1N1 pandemic viruses and their post-pandemic evolution pattern could further enhance their adaptation and pathogenicity in humans representing a major public health threat. Given that data on the dynamics and evolution of these viruses in Saudi Arabia is sparse we investigated the genetic diversity of circulating influenza A/H1N1pdm09 viruses from Jeddah, Saudi Arabia, by analyzing 39 full genomes from isolates obtained between 2014-2015, from patients with varying symptoms. Phylogenetic analysis of all gene segments and concatenated genomes showed similar topologies and co-circulation of clades 6b, 6b.1 and 6b.2, with clade 6b.1 being the most predominate since 2015. Most viruses were more closely related to the vaccine strain (Michigan/45/2015) recommended for the 2017/2018 season, than to the California/07/2009 strain. Low sequence variability was observed in the haemagglutinin protein compared to the neuraminidase protein. Resistance to neuraminidase inhibitors was limited as only one isolate had the H275Y substitution. Interestingly, two isolates had short PA-X proteins of 206 amino acids compared to the 232 amino acid protein found in most influenza A/H1N1pdm09 viruses. Together, the co-circulation of several clades and the predominance of clade 6b.1, despite its low circulation in Asia in 2015, suggests multiple introductions most probably during the mass gathering events of Hajj and Umrah. Jeddah represents the main port of entry to the holy cities of Makkah and Al-Madinah, emphasizing the need for vigilant surveillance in the kingdom.
This study was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), Jeddah, under grant no. (G-484-140-37). The authors, therefore, acknowledge with thanks DSR for technical and financial support.
Compliance with ethical standards
Conflict of interest
Authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 3.World Health Organization (WHO). Influenza (Seasonal) Fact sheet November 2016. http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed 15 Nov 2017
- 23.Memish ZA, Assiri A, Turkestani A et al (2015) Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect 21:571.e571–571.e578Google Scholar
- 25.World Health Organization (WHO) Sequencing primers WHO protocol. http://www.who.int/csr/resources/publications/swineflu/GenomePrimers_20090512.pdf?ua=1. Accessed 15 Nov 2017
- 26.Al-Saeed MS, El-Kafrawy SA, Farraj SA et al (2017) Phylogenetic characterization of circulating Dengue and Alkhumra Hemorrhagic Fever viruses in western Saudi Arabia and lack of evidence of Zika virus in the region: a retrospective study, 2010–2015. J Med Virol 89:1339–1346CrossRefPubMedGoogle Scholar
- 33.Nei M, Kumar S (2000) Molecular evolution and phylogenetics. Oxford University Press, New YorkGoogle Scholar
- 38.European Centre for Disease Prevention and Control. Influenza virus characterisation, summary Europe, November 2015. Stockholm: ECDC; 2015. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/influenza-virus-characterisation-november-2015.pdf. Accessed 15 Nov 2017
- 39.Katz J. Global Surveillance and Virus Characterization October 13, 2016. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM525491.pdf. Accessed 15 Nov 2017
- 40.Katz J. Global Surveillance and Virus Characterization March 4, 2016. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM492316.pdf. Accessed 15 Nov 2017
- 41.World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201609_recommendation.pdf?ua=1. Accessed 15 Nov 2017
- 42.Broberg E, Melidou A, Prosenc K et al (2016) Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe. Euro Surveill 21:pii=30184. https://doi.org/10.2807/1560-7917.ES.2016.21.13.30184
- 60.General Authority for Statistics, Kingdom of Saudi Arabia. Umrah Survey 2016. https://www.stats.gov.sa/sites/default/files/umrah_surveyen_0.pdf. Accessed 15 Nov 2017
- 61.General Authority for Statistics, Kingdom of Saudi Arabia. Hajj Statistics 2016. https://www.stats.gov.sa/sites/default/files/hajj_1437_en.pdf. Accessed 15 Nov 2017